statistiche ricercatore

Continente	#
AS - Asia	729
EU - Europa	616
NA - Nord America	572
SA - Sud America	138
AF - Africa	22
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.080

Nazione	#
US - Stati Uniti d'America	553
IT - Italia	310
SG - Singapore	233
CN - Cina	169
VN - Vietnam	129
BR - Brasile	97
HK - Hong Kong	83
RU - Federazione Russa	76
DE - Germania	36
FR - Francia	34
GB - Regno Unito	29
ES - Italia	27
FI - Finlandia	21
AR - Argentina	20
IN - India	20
KR - Corea	20
IE - Irlanda	17
PL - Polonia	15
ID - Indonesia	14
BD - Bangladesh	13
SE - Svezia	12
CA - Canada	10
NL - Olanda	10
CH - Svizzera	9
TR - Turchia	7
EC - Ecuador	6
ET - Etiopia	6
IQ - Iraq	6
JP - Giappone	6
PH - Filippine	6
AT - Austria	5
CO - Colombia	5
MX - Messico	5
VE - Venezuela	5
ZA - Sudafrica	5
MA - Marocco	4
PK - Pakistan	4
SA - Arabia Saudita	4
UA - Ucraina	4
BE - Belgio	3
UZ - Uzbekistan	3
AU - Australia	2
CL - Cile	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
IR - Iran	2
MM - Myanmar	2
NO - Norvegia	2
AL - Albania	1
AZ - Azerbaigian	1
BM - Bermuda	1
BO - Bolivia	1
CY - Cipro	1
DZ - Algeria	1
GA - Gabon	1
IL - Israele	1
KE - Kenya	1
KG - Kirghizistan	1
KZ - Kazakistan	1
MT - Malta	1
MY - Malesia	1
NG - Nigeria	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PY - Paraguay	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.080

Nome	#
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis	372
Idiopathic erythrocytosis: a germline disease?	368
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients	276
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)	228
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy	225
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis	214
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis	211
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis	211
Totale	2.105

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	36	0	0	0	0	0	0	0	0	13	7	7	9
2023/2024	216	7	9	13	13	18	25	27	11	31	20	20	22
2024/2025	619	24	52	40	24	39	29	31	18	58	102	75	127
2025/2026	1.234	167	90	121	157	123	57	232	57	85	122	23	0
Totale													2.105

Bicocca Open Archive